Adamis Pharmaceuticals Corp. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
-
3,774.70
4,080.60
5,095.80
18,332.70
19,271.60
Total Accounts Receivable
-
-
-
805.40
830.10
1,155.20
Inventories
-
-
-
942.10
1,824.60
3,279
Other Current Assets
64.30
179.50
71.00
227.00
474.20
1,878.40
Total Current Assets
64.30
3,954.20
4,151.60
7,070.20
21,461.50
25,584.30
Net Property, Plant & Equipment
-
77.70
58.30
4,897.00
6,559.70
9,867.90
Total Investments and Advances
-
127.50
-
-
-
-
Intangible Assets
-
8,737.80
7,767.00
25,776.70
23,327.30
20,851.20
Other Assets
286.60
-
85.00
42.50
54.70
2,054.70
Total Assets
350.90
12,897.20
12,061.90
37,786.40
51,403.20
58,358
ST Debt & Current Portion LT Debt
1,177.80
-
-
4,330.80
2,484.00
Accounts Payable
2,431.90
787.00
-
2,150.60
2,919.10
Other Current Liabilities
1,069.10
2,607.00
2,747.80
2,129.50
3,384.50
Total Current Liabilities
4,678.90
3,394.00
2,747.80
8,610.90
8,787.60
Long-Term Debt
-
-
-
3,067.10
2,583.10
Deferred Taxes
-
-
-
828.60
485.00
Total Liabilities
4,678.90
3,394.00
2,747.80
12,506.50
11,855.70
Common Equity (Total)
4,327.90
9,503.00
9,313.90
25,279.80
39,547.50
Total Shareholders' Equity
4,327.90
9,503.20
9,314.00
25,279.90
39,547.50
Total Equity
4,327.90
9,503.20
9,314.00
25,279.90
39,547.50
Liabilities & Shareholders' Equity
350.90
12,897.20
12,061.90
37,786.40
51,403.20
Preferred Stock (Carrying Value)
-
0.10
0.10
0.10
-
About Adamis Pharmaceuticals
View Profile
